CH622701A5 - - Google Patents

Download PDF

Info

Publication number
CH622701A5
CH622701A5 CH1548575A CH1548575A CH622701A5 CH 622701 A5 CH622701 A5 CH 622701A5 CH 1548575 A CH1548575 A CH 1548575A CH 1548575 A CH1548575 A CH 1548575A CH 622701 A5 CH622701 A5 CH 622701A5
Authority
CH
Switzerland
Prior art keywords
tetanus toxin
light chain
derivative
aldehyde
toxin
Prior art date
Application number
CH1548575A
Other languages
German (de)
English (en)
Inventor
Torsten Bertil Dr Helting
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Priority to AT388276A priority Critical patent/AT347448B/de
Priority to AU25885/77A priority patent/AU510241B2/en
Publication of CH622701A5 publication Critical patent/CH622701A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CH1548575A 1974-12-03 1975-11-28 CH622701A5 (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AT388276A AT347448B (de) 1975-11-28 1976-05-26 Verfahren zur herstellung von n-alkenyl-2- aminomethyl-pyrrolidinen
AU25885/77A AU510241B2 (en) 1975-11-28 1977-06-07 Producing tin or can covers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2457047A DE2457047C3 (de) 1974-12-03 1974-12-03 Verfahren zur Herstellung eines Derivates der leichten Kette des Tetanustoxins, dessen Verwendung zur Tetanusprophylaxe

Publications (1)

Publication Number Publication Date
CH622701A5 true CH622701A5 (sv) 1981-04-30

Family

ID=5932347

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1548575A CH622701A5 (sv) 1974-12-03 1975-11-28

Country Status (17)

Country Link
US (1) US4029765A (sv)
JP (1) JPS5182719A (sv)
AT (1) AT342764B (sv)
AU (1) AU504575B2 (sv)
BE (1) BE836228A (sv)
CA (1) CA1066621A (sv)
CH (1) CH622701A5 (sv)
DE (1) DE2457047C3 (sv)
DK (1) DK544175A (sv)
ES (1) ES443052A1 (sv)
FR (1) FR2293217A1 (sv)
GB (1) GB1531417A (sv)
IE (1) IE42760B1 (sv)
IL (1) IL48571A (sv)
LU (1) LU73900A1 (sv)
NL (1) NL7513941A (sv)
SE (1) SE431401B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264588A (en) * 1979-05-10 1981-04-28 The Charles River Breeding Laboratories, Inc. Vaccine for Clostridium perfringens type E enterotoxemia of rabbits
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
US4594336A (en) * 1982-09-28 1986-06-10 Institut Pasteur Thiolated polypeptide compound derived from a tetanus toxin fragment, the process for obtaining and its application
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
WO1997035612A1 (fr) * 1996-03-23 1997-10-02 The Research Foundation For Microbial Diseases Of Osaka University Antigene a fragment fonctionnel de la toxine du tetanos, et vaccin contre le tetanos
ES2275992T5 (es) * 2000-02-08 2011-05-18 Allergan, Inc. Composiciones farmacéuticas de toxina botulínica.
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
US8632785B2 (en) * 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
US20030138460A1 (en) * 2000-02-08 2003-07-24 Allergan, Inc Methods of treating animals with botulinum toxin pharmaceutical compositions
US7780967B2 (en) 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617344B2 (de) * 1967-05-06 1976-04-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines tetanus-impfstoffes
US3903262A (en) * 1972-03-13 1975-09-02 Cutter Lab Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use
DE2355094C3 (de) * 1973-11-03 1979-05-23 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tetanus-Impfstoffs

Also Published As

Publication number Publication date
ES443052A1 (es) 1977-07-16
GB1531417A (en) 1978-11-08
DE2457047A1 (de) 1976-06-10
FR2293217B1 (sv) 1978-07-28
DK544175A (da) 1976-06-04
AU504575B2 (en) 1979-10-18
DE2457047B2 (de) 1979-03-15
AU8716775A (en) 1977-06-09
US4029765A (en) 1977-06-14
SE7513606L (sv) 1976-06-04
AT342764B (de) 1978-04-25
IL48571A (en) 1980-02-29
IE42760L (en) 1976-06-03
SE431401B (sv) 1984-02-06
JPS5182719A (en) 1976-07-20
CA1066621A (en) 1979-11-20
FR2293217A1 (fr) 1976-07-02
DE2457047C3 (de) 1979-10-31
NL7513941A (nl) 1976-06-08
IL48571A0 (en) 1976-01-30
BE836228A (fr) 1976-06-03
IE42760B1 (en) 1980-10-08
ATA915575A (de) 1977-08-15
LU73900A1 (sv) 1976-11-11

Similar Documents

Publication Publication Date Title
DE68915045T2 (de) Reinigung von Pertussis-Toxinen und Herstellung von Vakzine.
DE2322552C2 (de) Verfahren zum Abtrennen von Protein A aus Staphylococcus aureus aus einer Flüssigkeit
DE69124235T2 (de) Reinigung und verwendung von pertactin, eines bordetella pertussis aussenmembranproteins
DE2457047C3 (de) Verfahren zur Herstellung eines Derivates der leichten Kette des Tetanustoxins, dessen Verwendung zur Tetanusprophylaxe
DE3032488C2 (sv)
DE60315827T2 (de) Verbesserte polysaccharid- und glykokonjugat-vakzine
DE3785157T2 (de) Verfahren zur herstellung von toxoid.
CH628246A5 (de) Verfahren zur herstellung eines schuetzenden pertussis-antigens.
DE2355094C3 (de) Verfahren zur Herstellung eines Tetanus-Impfstoffs
DE69731891T2 (de) Verfahren zur reinigung von gbs-toxin/cm101
DE2448530C3 (de) Verfahren zum Herstellen von Derivaten des Diphtherietoxins und diese enthaltende Mittel
DE69014541T2 (de) Chemisch modifizierte Allergene und Verfahren zu ihrer Herstellung.
DE69025375T2 (de) Verfahren
DE69416983T2 (de) Zederpollen-Proteine und ihre Verwendung
DE69329922T2 (de) Herstellung eines tetanusimpfstoffes
DE3779914T2 (de) Neue lectine, abgeleitet von bakteriellen haaren.
DE2404265C3 (de) Verfahren zum Abreichen von Immunglobulinen
DE2508396A1 (de) Verfahren zur gewinnung von virusproteinen, die dabei erhaltenen proteine und diese proteine als wirkstoffe enthaltende arzneimittel
WO1991004275A1 (de) Neue proteine geeignet zur bekämpfung von krankheiten sowie zum schutz von weidevieh gegen zecken
DE2634904A1 (de) Neue immunologische adjuvantien, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
Watanabe et al. Purification and some physicochemical properties of slow-reacting substance of anaphylaxis (SRS-A) from sensitized guinea pig lung
EP0083497A2 (en) Process for preparing modified allergens, their use in treating allergic conditions
DE2815758C3 (de) Peptidkomplexe aus DNS-haltigen Organismen
DE2634584C3 (de) Atoxisches, immunogenes Produkt aus Tetanus-Toxin
DE2510987C2 (de) Verfahren zur Herstellung eines Tetanusimpfstoffes

Legal Events

Date Code Title Description
PL Patent ceased